Newer Antidepressants and Panic Disorder: A Meta-analysis
Andrisano C, Chiesa A, Serretti A
Assessment of Self Taken Swabs Versus Clinician Taken Swab Cultures for Diagnosing Gonorrhoea in Women: Single Centre, Diagnostic Accuracy Study
Catherine M W Stewart, specialty registrar in genitourinary medicine, Sarah A Schoeman, consultant in genitourinary medicine, Russell A Booth, lead biomedical scientist, Susan D Smith, advanced biomedical scientist and training coordinator, Mark H Wilcox, professor of clinical microbiology, Janet D Wilson, consultant in genitourinary medicine
Assessment of Hepatitis B Vaccination and Compliance with Infection Control Among Dentists in Saudi Arabia
Ayman A. Al-Dharrab, Khalid H. Al-Samadani
Evaluation of ADC Measurements Among Solid Pancreatic Masses by Respiratory-triggered Diffusion-weighted MR Imaging with Inversion-recovery Fat-suppression Technique at 3.0T
Yao XZ, Yun H, Zeng MS, Wang H, Sun F, Rao SX, Ji Y
Nutritional Content of Supermarket Ready Meals and Recipes by Television Chefs in the United Kingdom: Cross Sectional Study
Simon Howard, specialty registrar in public health, Jean Adams, senior lecturer in public health, Martin White, professor of public health
Congenital Heart Defects in Down Syndrome Patients from Western Saudi Arabia
Jumana Y. Al-Aama, Nabeel S. Bondagji, Ashraf A. El-Harouni
Clinical Application of Image-Enhanced Minimally Invasive Robotic Surgery for Gastric Cancer: A Prospective Observational Study
Kim YM, Baek SE, Lim JS, Hyung WJ
Pain Over Speed Bumps in Diagnosis of Acute Appendicitis: Diagnostic Accuracy Study
Helen F Ashdown, academic clinical fellow in general practice, Nigel D'Souza, specialist registrar in general surgery, Diallah Karim, foundation trainee, Richard J Stevens, senior medical statistician, Andrew Huang, consultant colorectal and general surgeon, Anthony Harnden, university lecturer in general practice
Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
The GAUSS Randomized Trial
David Sullivan, MD; Anders G. Olsson, MD, PhD; Rob Scott, MD; Jae B. Kim, MD; Allen Xue, PhD; Val Gebski, MStat; Scott M. Wasserman, MD; Evan A. Stein, MD, PhD
Telaprevir Label Revised to Include Risk of Possible Fatal Skin Reactions
The US Food and Drug Administration (FDA) received reports of serious skin reactions, some fatal, in patients taking the telaprevir (Incivek) in combination with pegylated interferon alfa and ribavirin for the treatment of Hepatitis C.
Significantly, some patients died when they continued to receive telaprevir combination treatment after developing a worsening, or progressive rash and systemic symptoms.